Carlos F. Sánchez-Ferrer
He leads a UAM and IdiPAZ research group named with the acronym FARMAVASM, dedicated to the study of the mechanisms that produce deterioration of the vascular function in pathological conditions.
María Trinidad Herrero Ezquerro
Professor of Human Anatomy at the Faculty of Medicine of the University of Murcia. Director of the Official Aging Research Institute of Murcia.
Marc Ramis
He is a co-founder and CEO at Senolytic Therapeutics Inc., a pharmaceutical company that develops a novel class of medicines by targeting senescence cells. He is also supporting investments and strategic partnerships at Life Biosciences Inc. in Europe.
The researchers María Blasco and Manuel Collado will attend the Longevity World Forum to present the latest discoveries reached in Spain on delaying aging
The director of the CNIO will talk about mouse models with non-genetically modified hyper-long telomeres. The IDIS researcher will explain how a derivative of Digitalis or foxglove selectively eliminates senescent cells.
Manuel Serrano
Manuel Serrano obtained his PhD in 1991, from the Universidad Autónoma de Madrid. From 1991 to 1996, Serrano worked in the team of David Beach in Cold Spring Harbor Laboratory, NY. During this period, Serrano made his most important discovery with the identification and characterization of the gene p16.
Manuel Collado
Manuel Collado holds a PhD in Biology from the Universidad Autónoma de Madrid. Having previously worked in London, New York and at the Spanish National Cancer Research Centre (CNIO) in Madrid, he is currently at the Health Research Institute of Santiago de Compostela (IDIS).
Longevity World Forum confirms Valencia as its venue in 2019
The first conference on longevity in Europe will once again make Valencia the world scientific capital. This global meeting will be held for the second time on 13 and 14 November at the city’s conference centre.
“Imaging is the key to the health of the future focused on prevention and regular monitoring”
Ángel Alberich-Bayarri, director and founder of QUIBIM, will participate for the second year running at the Longevity World Forum. His intervention, which will form part of the session on RDI in longevity, will reveal the applications and possibilities of artificial intelligence in this field.
Longevity World Forum completes its programme for 2019 with a symposium at the Príncipe Felipe Research Centre
The doctors María Blasco and Pura Muñoz will be two of the speakers of this conference dedicated to aging and metabolism. The event will take place on Wednesday 13 November at the facilities of the Príncipe Felipe Research Centre.
Manuel Serrano: “I don’t know how to use the word immortality. I don’t see any point in talking about something so intangible”
Manuel Serrano is internationally recognised in the field of tumour suppression. In addition to his discovery of the p16 gene, one of his most important discoveries has been the identification of cellular senescence as a main anti-oncogenic response. In this the second edition of Longevity World Forum, he will share his extensive experience, as well as the advances on which he is currently working at the Institute for Research in Biomedicine (IRB Barcelona).